Silvia de Sanjosé

Head of Cancer Epidemiology Research Programme
Department: PREC UNIC I&I - Leadership Team

Medical degree (University of Barcelona, Spain 1980); Specialty in Family practice (University of Barcelona, Spain 1983); Master of Science in Epidemiology (London School of Hygiene and Tropical Medicine, University of London (1986); Doctoral degree (London School of Hygiene and Tropical University, University of London 1989). Medical officer in training at the General Hospital of Alicante, Spain (1981-82) and at the Primary Health Centre of Cornella, Spain (1983); Research fellow in the Institut Municipal de Salut Pública of Barcelona, Spain (1984-85); Research fellow in the Department of Epidemiology of the London School of Hygiene and Tropical Medicine, London, UK (1988) and at the Unit of Field and Intervention Studies of the International Agency for Research on Cancer (IARC), Lyon, France (1989-1993); Senior Epidemiologist and Head of the Cancer Epidemiology Research Program at the Catalan Institute of Oncology, Barcelona, Spain (1993-to date); Rockville, USA (July 2002-2003 Sabbatical period).

Dr de Sanjosé has successfully interacted with the majority of international groups addressing public health issues related to HPV and cervical cancer, including World Health Organization (WHO), the International Agency for Research on Cancer (IARC), the National Cancer Institute (NCI), the Harvard University School of Public Health. She also has an active role in the International Lymphoma Epidemiology Consortium (INTERLYMPH).

Dr de Sanjosé is a leading researcher in the field of cancer-associated infectious diseases. She was a key figure in early studies investigating the role of HPV and cervical carcinogenesis. For the past eight years, Dr de Sanjosé has been coordinator of EPILYMPH_Spain and EPILYMPH_Europe. Dr de Sanjosé is part of the Spanish network of Excellency CIBER on Epidemiology and Public Health (CIBERESP).

Dr de Sanjosé has played an important role in the evaluation of the infectious, environmental and genetic aetiology of lymphomas. She has coordinated several aspects of the international case-control study based on nine European countries (total subject enrolment: 2 300 cases and 2 300 controls). Project research lines include studies on viral infections (e.g. EBV and HHV-8 associated to lymphomas), hair dyes and lymphomas, chronic medication and lymphomas, immunological pathways associated to lymphomas, family history of cancer and lymphomas and genetic testing.

Dr de Sanjosé is principal investigator of an international prevalence study of several infections agents on herpes virus 8 and a sister study based on the prevalence study. The study will involve the typing of herpes virus 8 of over 10 000 women from nine countries around the world.

Dr de Sanjosé is involved in the multi-centric case-control study on invasive cervical cancer that is being coordinated by the IARC and in several other HPV-related projects around the world. Among these projects, she is coordinating the field work of the Retrospective International Survey of HPV Types in Cervical Cancer (PI: Dr F.X. Bosch). The study aims are to: (1) describe secular trends in the distribution of HPV types in invasive cervical cancer and (2) describe the HPV type distribution in high risk areas for cervical cancer where the available information is scarce.
Dr de Sanjosé has coordinated the elaboration of a screening program of cervical cancer in Catalonia that affects all the feminine population. This program started in June 2006.

ResearcherID: H-6339-2014